BMC Research Notes (Jan 2021)

The clinical value of ficolin-3 gene polymorphism in rheumatic heart disease. An Egyptian adolescents study

  • Maher H. Gomaa,
  • Emad Gamil Khidr,
  • Ahmed Elshafei,
  • Hala S. Hamza,
  • Aya M. Fattouh,
  • Ahmed A. El-Husseiny,
  • Ahmed Aglan,
  • Mahmoud Gomaa Eldeib

DOI
https://doi.org/10.1186/s13104-021-05450-w
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 6

Abstract

Read online

Abstract Objective Ficolin-3 is one of the innate immunity molecules that was thought to play a pivotal role in Streptococcus pyogenes autoimmunity and its complications; rheumatic fever (RF) and rheumatic heart disease (RHD). We aimed to disclose if there is an association between ficolin-3 (FCN3) gene polymorphisms (rs4494157 and rs10794501) and RF with or without RHD for the first time in Egyptian adolescents. Results Serum ficolin-3 level was significantly elevated in patients suffering from RF with and without RHD in comparison with control. Regarding FCN3 gene (rs4494157) polymorphism, a significant correlation was found between the A allele and the susceptibility to RF with or without RHD (OR = 2.93, P = 0.0002 and OR = 2.23, P = 0.008 respectively). Besides, AA homozygous genotype showed a significant association with RHD risk (OR = 3.47, P = 0.026). Patients carrying the A allele (CA + AA) had significantly higher serum ficolin-3 than those carrying the CC genotype (P ˂ 0.0001). While the frequency of (rs10794501) polymorphism revealed no significant differences between the controls and RF patients with or without RHD (OR = 1.43, P = 0.261 and OR = 1.48, P = 0.208 respectively).

Keywords